What does it do?
Arteris is a growth-stage business that earns money by licensing proprietary semiconductor designs that manage how data moves between different components on a single chip. It primarily uses a two-part revenue model: customers pay an upfront license fee to use the technology during the chip design phase, followed by recurring royalties for every physical chip shipped that contains Arteris IP. This "network-on-chip" (NoC) technology is essentially the traffic controller for data, ensuring that processors, memory, and sensors can communicate without bottlenecks, which is critical for the power-hungry requirements of modern artificial intelligence.
Where does revenue come from?
The vast majority of revenue comes from high-margin intellectual property licenses and support fees. Licensing and maintenance made up approximately 86% of revenue in the most recent quarter, while variable royalties contributed about 9% as customers ramped up production volumes. Its business is globally diversified, serving major tech hubs in the United States, China, Europe, and the Asia Pacific region.
Revenue Breakdown
Revenue by Geography
Who are its customers?
Arteris serves over 250 customers including global semiconductor leaders like NXP and Li Auto who are building advanced AI and automotive chips. It currently manages a record Annual Contract Value plus royalties of $99.5 million, which has grown 44% year-over-year. In the last year, customer design activity spiked by 21%, with the majority of new designs incorporating some form of AI compute. Its technology is currently shipped in over 4 billion units worldwide, primarily in markets requiring high performance and low power, such as autonomous driving and data center AI infrastructure.
What gives it staying power?
Arteris has staying power through high switching costs because its interconnect fabric is deeply woven into the physical layout of a chip. Once a designer integrates Arteris IP into a system-on-chip floorplan, replacing it would require a complete and costly redesign of the entire silicon architecture.
Where is it headed?
The company is making a major strategic bet on the industry's transition to multi-die chiplet architectures. Management believes that as chips get too large to manufacture as a single piece, they will be broken into smaller chiplets that require Arteris's advanced interconnects to function as a unified system.
Arteris is seeing a sharp acceleration in top-line growth with second-quarter 2026 revenue jumping 46% to $24.1 million. This trend is supported by an even faster 65% growth in royalties, signaling that earlier customer designs are now hitting the high-volume production phase.
Free cash flow is finally reaching a positive inflection point with management guiding for $5 million to $9 million in cash generation for the full year 2026. This shift reveals that the business is beginning to leverage its fixed engineering costs against a rapidly growing base of high-margin licensing fees.
The company maintains a healthy balance sheet with $93.3 million in cash and minimal debt after recently raising capital through an at-the-market offering. This net cash position provides the necessary cushion to fund its high research and development spending, which consumed nearly 70% of revenue in the latest quarter.
Arteris is a high-growth, high-margin IP business that is successfully transitioning from a cash-burning startup to a self-funding growth engine.
Arteris does not pay a dividend and focuses all capital on research and development and strategic acquisitions. It has never paid a cash dividend to shareholders and has no current plans to start. While it does not have a formal buyback program, the share count rose by approximately 11% over the past year as the company issued new stock to raise cash and fund employee compensation. Investors should view this as a pure growth holding where value is created through business expansion rather than cash returns.
Customer engagement is at record levels with Annual Contract Value plus royalties reaching $99.5 million. This growth is driven by the fact that the majority of new chip designs now incorporate AI compute, making Arteris's communication fabric an essential rather than optional component.
Operating losses remain heavy at $13.9 million for the quarter as the company continues to spend aggressively on engineering. The critical signal to watch is whether the guided shift to positive free cash flow in late 2026 actually materializes to prove the business model is sustainable.
The semiconductor intellectual property (IP) market is roughly $7 billion today and is growing at nearly 20% annually as chip designs become too complex for companies to build entirely in-house. The industry is on track to exceed $15 billion by 2030, driven by the explosion of AI-specific hardware and the transition to chiplet-based designs. This is a high-margin industry that rewards specialized technical leads, and Arteris stands as a dominant specialist in the interconnect niche, making it a critical partner for anyone building advanced AI silicon.
The competitive dynamic in semiconductor IP is rationally structured but requires constant technical innovation to prevent commoditization. Barriers to entry are exceptionally high because a single error in the interconnect fabric can render a $100 million chip project useless. This creates a "nobody ever got fired for buying IBM" effect that protects established players.
Synopsys and Cadence are the primary threats, leveraging their massive size to bundle interconnect IP with the software tools designers already use. Arm also represents a significant force as it controls the most common CPU architecture and increasingly integrates its own communication fabrics. The most dangerous threat is a shift toward integrated design platforms where giants like Synopsys can offer "good enough" interconnects for free to win the larger software contract.
Arteris is currently holding its ground and gaining share in high-performance AI and automotive applications. Its 44% growth in annual contract value suggests that its specialized "Network-on-Chip" technology is outperforming the generic offerings of larger competitors.
Arteris's protection comes primarily from massive switching costs that are built into the physical design of the chip. Once a customer chooses Arteris for their communication fabric, the interconnect is physically "hardened" into the silicon layout, making a switch to a rival nearly impossible without restarting the entire multi-year project. The record $135 million in remaining performance obligations proves that customers are committing to this technology for years into the future.
The company's 87% non-GAAP gross margins and 21% growth in design starts collectively prove that its technical lead is real and defensible. These numbers indicate that Arteris can maintain high prices even when competing against much larger rivals who offer broader product suites. The business is reaching a scale where the growing base of production royalties will provide a high-quality, recurring cash stream.
The moat is strengthening as the industry shifts toward chiplets. As chips move from single pieces of silicon to complex systems of multiple dies, the communication between those pieces becomes the most valuable part of the design, significantly increasing the importance and defensibility of Arteris's core technology.
Delivered 46% revenue growth and record ACV while guiding for positive free cash flow.
Acquired Cycuity for $43M to expand into high-margin hardware security verification.
CEO Karel Janac holds a significant stake, but share dilution remains high at 11%.
Capital Allocation Track Record
Management has demonstrated strong strategic judgment by positioning Arteris at the center of the AI and chiplet transition long before it became the industry standard. CEO Karel Charles Janac has successfully scaled the company from a niche IP provider to a critical infrastructure player, maintaining high gross margins and recently inflecting the business toward positive free cash flow. Their ability to attract Tier-1 customers like NXP and Arm while managing high R&D requirements suggests a leadership team that understands the long-term value of technical specialization.
The main governance risk is the company's continued reliance on equity issuance to fund its growth, which has led to double-digit share dilution over the past year. While the CEO’s founder-level involvement provides strong strategic continuity, the transition to a new CFO, Saurabh Sinha, in late 2026 will be a key period for the company to prove it can maintain financial discipline. Investors should watch whether the team can successfully integrate the Cycuity acquisition without losing focus on the core interconnect growth engine.
We expect revenue to grow from $0.1B in FY2026 to $0.1B in FY2031 (~9% CAGR), with EPS growing from $-0.18 to $0.79. We expect 10% market share in the on-chip interconnect space as Arteris gains ground on in-house designs during this early AI expansion cycle. Fixed engineering costs are leveraged over a growing base of high-margin royalty revenue as chip designs move into production. EPS grows as the company inflects to profitability, though gains are partially offset by continued share dilution. Operating margin expected to reach ~45% by FY2031.
Chiplet transition increases content and value per design. As chips move from single pieces of silicon to multi-die systems, the interconnect becomes the most complex and valuable part of the design.
Cycuity acquisition creates unique security-plus-interconnect bundle. Integrating hardware-level security directly into the data fabric allows Arteris to charge higher licensing fees for mission-critical chips.
Production royalties ramp as AI designs enter high-volume manufacturing. The record design starts today convert into high-margin, recurring royalty checks once customers begin shipping millions of chips in future years.
Large EDA players bundle competing IP to squeeze out specialists. If Synopsys or Cadence offers "good enough" interconnects for free, Arteris could lose the ability to win new non-AI designs.
Major AI chipmakers move interconnect design entirely in-house. If the largest customers like Nvidia or Broadcom stop using external IP for their communication fabrics, the addressable market shrinks.
Continued share dilution offsets the benefits of business growth. High stock-based compensation and capital raises could continue to shrink the slice of the company owned by existing shareholders.
Below is our estimate of current and future fair value, with detailed reasoning and assumptions. Fair value is a judgment, not a fact, and other analysts will likely land on different numbers. Use it as one data point in your research, and apply your own discretion in any investing decision.
We value Arteris based on what the business should be worth in five years, then bring that value back to today’s dollars. This approach is the best fit because the company is currently losing money while it builds for the future AI chip market. Looking at today's losses alone would not capture the value of the royalties it expects to collect once its customers start shipping their new designs in large volumes.
We expect the company to earn $0.79 per share by 2031, which at a 30x multiple suggests a $24 share price in five years, or $15 today when adjusted for time. Larger rivals in the chip design software space like Synopsys and Cadence trade between 35x and 45x their earnings, but we used a lower 30x multiple to account for Arteris's smaller size and higher risk. This profit estimate comes from Wall Street analyst expectations for the company's long-term growth path.
If we value the company on next year's expected sales instead, using the 4.5x multiple common for semiconductor software companies, we get a fair value of $11. This is about 27% lower than our $15 primary estimate, which shows that our main valuation is already giving the company a lot of credit for a very successful long-term shift to high-margin royalties. Because the two methods disagree by a notable margin, we trust the discounted terminal value more, as it specifically accounts for the unique royalty ramp that defines the business model.
The biggest risk is that the industry-wide shift to "chiplets" takes longer to reach mass production than Arteris expects. This would delay the high-margin royalty payments the company needs to become profitable, potentially knocking fair value down toward the $11 bear case. Watch for any delays in customer product launches that use the FlexGen platform as an early warning sign.
Bear case ($11): Royalty revenue growth falls below 40% annually as older chip designs are retired faster than new ones arrive; or Research and development costs stay above 60% of sales through 2028, preventing the company from reaching GAAP profitability.
Bull case ($22): Chiplet-based designs reach 25% of the total contract mix by 2027, driving higher upfront licensing fees; or The company achieves non-GAAP operating profitability in Q4 2026 and maintains it through a full fiscal year.
Clearthesis wrote this report from 47 sources, including SEC filings, analyst estimates, industry research, and recent news.
How did you like this thesis?
Your feedback helps us make reports better for you
© 2026 Clearthesis.ai · Report generated on October 16, 2026
This is an AI-generated analysis for informational purposes only and does not constitute financial advice. Data and analysis may not reflect recent developments if viewed significantly after the generation date. Always conduct your own due diligence before making any investment decisions.